Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J K E Veraart

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Tijdschrift Voor Psychiatrie|September 13, 2019
[Off-label ketamine treatment for treatment-resistant depression: win-win?]S Y Smith-Apeldoorn, J K E Veraart, R A Schoevers
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 25, 2026
A call for the systematic assessment of sexual adverse events in ketamine and esketamine trials and clinical practiceS Y Smith-Apeldoorn, J K E Veraart, J Kamphuis, et al.
Tijdschrift Voor Psychiatrie|June 16, 2015
[The type of agent auto-intoxication and the degree of suicidal intent]J K E Veraart, D Coric, M van der Erf, et al.
Tijdschrift Voor Psychiatrie|August 21, 2020
[Psychedelics for existential distress in terminally ill patients]N Schimmel, J J Breeksema, J K E Veraart, et al.
Tijdschrift Voor Psychiatrie|August 21, 2020
[Psychedelics in the treatment of depression, anxiety, and obsessive-compulsive disorder]J J Breeksema, W van den Brink, J K E Veraart, et al.
Heliyon|May 24, 2023
Repeated oral esketamine in patients with treatment resistant depression and comorbid posttraumatic stress disorderJ K E Veraart, M van Westenbrugge, J E van Wulfften Palthe, et al.
Tijdschrift Voor Psychiatrie|August 21, 2020
[Ketamine as an anesthetic, analgesic and anti-depressant]S Y Smith-Apeldoorn, J K E Veraart, J Kamphuis, et al.
Tijdschrift Voor Psychiatrie|April 29, 2021
J K E Veraart, S M van Belkum, P F J Oostelbos, et al.
Clinical Psychology Review|February 6, 2026
Ketamine-assisted psychotherapies for mental disorders: A historical overview and systematic reviewJ K E Veraart, N Schimmers, J J Breeksema, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Tijdschrift Voor Psychiatrie|September 13, 2019
[Off-label ketamine treatment for treatment-resistant depression: win-win?]S Y Smith-Apeldoorn, J K E Veraart, R A Schoevers
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 25, 2026
A call for the systematic assessment of sexual adverse events in ketamine and esketamine trials and clinical practiceS Y Smith-Apeldoorn, J K E Veraart, J Kamphuis, et al.
Tijdschrift Voor Psychiatrie|June 16, 2015
[The type of agent auto-intoxication and the degree of suicidal intent]J K E Veraart, D Coric, M van der Erf, et al.
Tijdschrift Voor Psychiatrie|August 21, 2020
[Psychedelics for existential distress in terminally ill patients]N Schimmel, J J Breeksema, J K E Veraart, et al.
Tijdschrift Voor Psychiatrie|August 21, 2020
[Psychedelics in the treatment of depression, anxiety, and obsessive-compulsive disorder]J J Breeksema, W van den Brink, J K E Veraart, et al.
Heliyon|May 24, 2023
Repeated oral esketamine in patients with treatment resistant depression and comorbid posttraumatic stress disorderJ K E Veraart, M van Westenbrugge, J E van Wulfften Palthe, et al.
Tijdschrift Voor Psychiatrie|August 21, 2020
[Ketamine as an anesthetic, analgesic and anti-depressant]S Y Smith-Apeldoorn, J K E Veraart, J Kamphuis, et al.
Tijdschrift Voor Psychiatrie|April 29, 2021
J K E Veraart, S M van Belkum, P F J Oostelbos, et al.
Clinical Psychology Review|February 6, 2026
Ketamine-assisted psychotherapies for mental disorders: A historical overview and systematic reviewJ K E Veraart, N Schimmers, J J Breeksema, et al.
Pageof 1